Home › Companies › Prime Medicine, Inc. › 2025-2026
At Prime Medicine, Inc.'s 2 shareholder meetings in the 2025-2026 proxy season (held August 1, 2025 and June 5, 2026), 50 asset managers reported how they voted in their SEC Form N-PX filings, covering 630 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held June 5, 2026 — To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public… — Prime Medicine, Inc.'s filing reports the proposal as approved, with 99.9% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Prime Medicine, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 8, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Prime Medicine, Inc.’s Form 8-K, filed June 8, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 5, 2026: 3 items on Prime Medicine, Inc.’s Form 8-K, filed June 8, 2026: 2 elected · 1 approved.
Meeting of August 1, 2025: 2 items on Prime Medicine, Inc.’s Form 8-K, filed August 5, 2025: 2 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Prime Medicine, Inc. in the interactive database Compare manager voting policies
These tallies are Prime Medicine, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 8, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. Prime Medicine, Inc. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael Kelly | 107,059,058 | -- | -- | 3,047,945 | 30,277,721 | 97% | Elected | — |
| Elect Director: David Schenkein, M.D. | 87,522,409 | -- | -- | 22,584,594 | 30,277,721 | 79% | Elected | — |
| 2. Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 139,989,201 | 101,259 | 294,264 | -- | -- | 99.9% | Approved | — |
Source: Prime Medicine, Inc., Form 8-K, filed with the SEC on June 8, 2026 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. Option Repricing Proposal | 71,563,193 | 13,491,029 | 95,830 | -- | -- | 84% | Approved | — |
| 2. Although the Adjournment Proposal was deemed not necessary because there was a quorum present and there were sufficient proxies at the time of the Special Meeting to approve the Option Repricing Proposal, it | 69,859,419 | 15,141,941 | 148,692 | -- | -- | 82% | Approved | — |
Source: Prime Medicine, Inc., Form 8-K, filed with the SEC on August 5, 2025 — read the filing on EDGAR.
Each item below shows how the 50 asset managers that disclosed a Prime Medicine, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Prime Medicine, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held June 5, 2026.
28% of fund votes cast · no official result
The 31 asset managers below reported 3,298,978 for, 8,664,468 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 3,128 | 0 | 0 | 4,371,698 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 3,274,060 | Withhold |
| Vanguard | 2,909,071 | 0 | 0 | 0 | For |
| Goldman Sachs | 378,756 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 246,748 | Withhold |
| Fidelity | 0 | 0 | 0 | 184,479 | Withhold |
| Equitable | 0 | 0 | 0 | 166,435 | Withhold |
| ProShares | 0 | 0 | 0 | 117,650 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 66,200 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 53,562 | Withhold |
| Voya | 0 | 0 | 0 | 40,295 | Withhold |
| Pacific Life | 0 | 0 | 0 | 39,109 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 34,779 | Withhold |
| DWS | 0 | 0 | 0 | 14,834 | Withhold |
| Nationwide | 4,786 | 0 | 0 | 4,771 | Mixed |
| Calvert | 0 | 0 | 0 | 8,407 | Withhold |
| Brighthouse | 0 | 0 | 0 | 7,822 | Withhold |
| SA FUNDS INVESTMENT TRUST | 0 | 0 | 0 | 5,776 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 5,687 | Withhold |
| Morgan Stanley | 0 | 0 | 0 | 4,528 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 4,500 | Withhold |
| Principal | 0 | 0 | 0 | 4,076 | Withhold |
| Strategy Shares | 3,237 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 2,709 | Withhold |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 2,350 | Withhold |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Meeting held June 5, 2026.
99.0% of fund votes cast · no official result
The 31 asset managers below reported 11,852,262 for, 111,184 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 4,369,134 | 0 | 0 | 5,692 | For |
| T. Rowe Price | 3,274,060 | 0 | 0 | 0 | For |
| Vanguard | 2,909,071 | 0 | 0 | 0 | For |
| Goldman Sachs | 378,756 | 0 | 0 | 0 | For |
| TIAA | 246,748 | 0 | 0 | 0 | For |
| Fidelity | 184,479 | 0 | 0 | 0 | For |
| Equitable | 66,735 | 0 | 0 | 99,700 | Mixed |
| ProShares | 117,650 | 0 | 0 | 0 | For |
| Lincoln Financial | 66,200 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 53,562 | 0 | 0 | 0 | For |
| Voya | 40,295 | 0 | 0 | 0 | For |
| Pacific Life | 39,109 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 34,779 | 0 | 0 | 0 | For |
| DWS | 14,834 | 0 | 0 | 0 | For |
| Nationwide | 9,557 | 0 | 0 | 0 | For |
| Calvert | 8,407 | 0 | 0 | 0 | For |
| Brighthouse | 7,822 | 0 | 0 | 0 | For |
| SA FUNDS INVESTMENT TRUST | 0 | 0 | 0 | 5,776 | Withhold |
| Columbia Threadneedle | 5,687 | 0 | 0 | 0 | For |
| Morgan Stanley | 4,528 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 4,500 | 0 | 0 | 0 | For |
| Principal | 4,076 | 0 | 0 | 0 | For |
| Strategy Shares | 3,237 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 2,709 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 2,350 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Meeting held June 5, 2026.
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: DIRECTOR: DAVID SCHENKEIN, M.D.
Prime Medicine, Inc.’s own tally for this item (“Elect Director: David Schenkein, M.D.”): 87,522,409 for, 22,584,594 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Each of the following nominees was elected as a Class I Director to serve until the Company's 2029 annual meeting of stockholders, and until his respective successor shall have been duly elected and qualified, or until his earlier death, resignation or removal, based on the following v…”
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 18 asset managers below reported 6,152,735 for, 1,077,919 withheld, 1,529,540 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 4,681,668 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 1,448,873 | 0 | Abstain |
| ARK Venture Fund | 1,357,869 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 917,828 | Withhold |
| Global X | 0 | 0 | 0 | 79,046 | Withhold |
| Bridge Builder Trust | 0 | 0 | 44,166 | 0 | Abstain |
| Jacob Funds Inc. | 40,000 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 37,515 | Withhold |
| Lincoln Financial | 36,342 | 0 | 0 | 0 | For |
| JPMorgan | 33,056 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 0 | 0 | 27,416 | Withhold |
| John Hancock | 0 | 0 | 19,329 | 0 | Abstain |
| Jackson National | 0 | 0 | 17,075 | 0 | Abstain |
| Vanguard | 3,800 | 0 | 38 | 5,894 | Mixed |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 6,345 | Withhold |
| Nationwide | 0 | 0 | 0 | 3,321 | Withhold |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 554 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 59 | 0 | Abstain |
Meeting held June 5, 2026.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: DIRECTOR: MICHAEL KELLY
Prime Medicine, Inc.’s own tally for this item (“Elect Director: Michael Kelly”): 107,059,058 for, 3,047,945 withheld, per its Form 8-K filed June 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Each of the following nominees was elected as a Class I Director to serve until the Company's 2029 annual meeting of stockholders, and until his respective successor shall have been duly elected and qualified, or until his earlier death, resignation or removal, based on the following v…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 18 asset managers below reported 8,736,666 for, 6,448 withheld, 17,080 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 4,681,668 | 0 | 0 | 0 | For |
| BlackRock | 1,448,873 | 0 | 0 | 0 | For |
| ARK Venture Fund | 1,357,869 | 0 | 0 | 0 | For |
| Charles Schwab | 917,828 | 0 | 0 | 0 | For |
| Global X | 79,046 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 44,166 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 40,000 | 0 | 0 | 0 | For |
| SEI | 37,515 | 0 | 0 | 0 | For |
| Lincoln Financial | 36,342 | 0 | 0 | 0 | For |
| JPMorgan | 33,056 | 0 | 0 | 0 | For |
| Russell Investments | 27,416 | 0 | 0 | 0 | For |
| John Hancock | 19,329 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 17,075 | 0 | Abstain |
| Vanguard | 3,833 | 0 | 5 | 5,894 | Mixed |
| Venerable Variable Insurance Trust | 6,345 | 0 | 0 | 0 | For |
| Nationwide | 3,321 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 554 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 59 | 0 | 0 | 0 | For |
Meeting held August 1, 2025.
0.6% of fund votes cast · no official result
Description as filed by funds: TO APPROVE A PROPOSAL TO ADJOURN THE SPECIAL MEETING TO A LATER DATE, IF NECESSARY OR APPROPRIATE, TO PERMIT FURTHER SOLICITATION AND VOTE OF ADDITIONAL PROXIES IN THE EVENT THAT THERE ARE INSUFFICIENT VOTES FOR, OR OTHERWISE IN CONNECTION WITH, THE APPROVAL OF THE OPTION REPRICING PROPOSAL AT THE TIME OF THE SPECIAL MEETING.
The 33 asset managers below reported 22,630 for, 4,453,069 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 0 | 2,211,100 | 0 | 0 | Against |
| T. Rowe Price | 0 | 1,193,021 | 0 | 0 | Against |
| Vanguard | 0 | 514,741 | 0 | 0 | Against |
| BlackRock | 0 | 169,653 | 0 | 0 | Against |
| Equitable | 0 | 125,870 | 0 | 0 | Against |
| Lincoln Financial | 0 | 45,000 | 0 | 0 | Against |
| Charles Schwab | 0 | 44,949 | 0 | 0 | Against |
| Global X | 0 | 30,824 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 27,401 | 0 | 0 | Against |
| Investment Managers Series Trust II | 22,312 | 0 | 0 | 0 | For |
| Fidelity | 0 | 14,204 | 0 | 0 | Against |
| John Hancock | 0 | 11,476 | 0 | 0 | Against |
| Goldman Sachs | 0 | 11,191 | 0 | 0 | Against |
| DWS | 0 | 8,984 | 0 | 0 | Against |
| SEI | 0 | 7,800 | 0 | 0 | Against |
| Pacific Life | 0 | 6,673 | 0 | 0 | Against |
| Nationwide | 0 | 5,673 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 4,386 | 0 | 0 | Against |
| Principal | 0 | 3,996 | 0 | 0 | Against |
| Calvert | 0 | 3,901 | 0 | 0 | Against |
| ProShares | 0 | 2,857 | 0 | 0 | Against |
| State Street | 0 | 2,509 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 0 | 2,350 | 0 | 0 | Against |
| TIAA | 0 | 2,011 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 0 | 1,500 | 0 | 0 | Against |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Meeting held August 1, 2025.
Combines 2 wordings of this item as funds reported it.
84% Approved · of votes cast
Description as filed by funds: To approve the repricing of certain outstanding stock options that have been granted under the Company's 2019 Stock Option and Grant Plan and/or the 2022 Stock Option and Incentive Plan (the "Option Repricing Proposal").
Prime Medicine, Inc.’s own tally for this item (“1. Option Repricing Proposal”): 71,563,193 for, 13,491,029 against — passed, per its Form 8-K filed August 5, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 1 – The Option Repricing Proposal was approved, based on the following votes:”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 34 asset managers below reported 1,215,694 for, 3,260,055 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 0 | 2,211,100 | 0 | 0 | Against |
| T. Rowe Price | 1,192,967 | 54 | 0 | 0 | For |
| Vanguard | 0 | 514,741 | 0 | 0 | Against |
| BlackRock | 0 | 169,653 | 0 | 0 | Against |
| Equitable | 0 | 125,870 | 0 | 0 | Against |
| Lincoln Financial | 0 | 45,000 | 0 | 0 | Against |
| Charles Schwab | 0 | 44,949 | 0 | 0 | Against |
| Global X | 0 | 30,824 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 27,401 | 0 | 0 | Against |
| Investment Managers Series Trust II | 22,312 | 0 | 0 | 0 | For |
| Fidelity | 0 | 14,204 | 0 | 0 | Against |
| John Hancock | 0 | 11,476 | 0 | 0 | Against |
| Goldman Sachs | 0 | 11,191 | 0 | 0 | Against |
| DWS | 0 | 8,984 | 0 | 0 | Against |
| SEI | 0 | 7,800 | 0 | 0 | Against |
| Pacific Life | 0 | 6,673 | 0 | 0 | Against |
| Nationwide | 0 | 5,673 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 4,386 | 0 | 0 | Against |
| Principal | 0 | 3,996 | 0 | 0 | Against |
| Calvert | 0 | 3,901 | 0 | 0 | Against |
| ProShares | 0 | 2,857 | 0 | 0 | Against |
| State Street | 0 | 2,509 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 0 | 2,350 | 0 | 0 | Against |
| TIAA | 0 | 2,011 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 0 | 1,500 | 0 | 0 | Against |
Showing the 25 largest of 34 asset managers. All 34 are in the interactive database (link above).
Meeting held June 5, 2026.
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
Prime Medicine, Inc.’s own tally for this item (“2. Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 139,989,201 for, 101,259 against — passed, per its Form 8-K filed June 8, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified, based on the following votes:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 20,864,714 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 4,681,668 | 0 | 0 | 0 | For |
| State Street | 4,374,826 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,274,060 | 0 | 0 | 0 | For |
| Vanguard | 2,918,803 | 0 | 0 | 0 | For |
| BlackRock | 1,448,873 | 0 | 0 | 0 | For |
| ARK Venture Fund | 1,357,869 | 0 | 0 | 0 | For |
| Charles Schwab | 917,828 | 0 | 0 | 0 | For |
| Goldman Sachs | 378,756 | 0 | 0 | 0 | For |
| TIAA | 246,748 | 0 | 0 | 0 | For |
| Fidelity | 184,479 | 0 | 0 | 0 | For |
| Equitable | 166,435 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 141,074 | 0 | 0 | 0 | For |
| ProShares | 117,650 | 0 | 0 | 0 | For |
| Lincoln Financial | 102,542 | 0 | 0 | 0 | For |
| Global X | 79,046 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 53,562 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 44,166 | 0 | 0 | 0 | For |
| Voya | 40,295 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 40,000 | 0 | 0 | 0 | For |
| Pacific Life | 39,109 | 0 | 0 | 0 | For |
| SEI | 37,515 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 34,779 | 0 | 0 | 0 | For |
| JPMorgan | 33,056 | 0 | 0 | 0 | For |
| Russell Investments | 27,416 | 0 | 0 | 0 | For |
| John Hancock | 19,329 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 180,617,451 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARK ETF Trust | 2.59% |
| 2 | State Street | 2.42% |
| 3 | T. Rowe Price | 1.81% |
| 4 | Vanguard | 1.62% |
| 5 | BlackRock | 0.80% |
| 6 | ARK Venture Fund | 0.75% |
| 7 | Charles Schwab | 0.51% |
| 8 | Goldman Sachs | 0.21% |
| 9 | TIAA | 0.14% |
| 10 | Fidelity | 0.10% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | UNITED CAPITAL FINANCIAL ADVISORS, LLC | <0.01% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| David Liu | 11.26% | DEF14A |
| Robert Nelsen | 10.29% | DEF14A |
| Entities affiliated with ARCH Venture Partners | 10.24% | DEF14A |
| Entities affiliated with GV | 9.17% | DEF14A |
| Bristol-Myers Squibb Company | 6.09% | DEF14A |
| BlackRock | 4.71% | 13F |
| Vanguard Group | 3.58% | 13F |
| State Street | 3.51% | 13F |
| T. Rowe Price Investment Management, Inc. | 3.32% | 13G |
| Keith Gottesdiener, M.D. | 2.98% | DEF14A |
Percentages above are of 180,617,451 shares outstanding, as reported by Prime Medicine, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Prime Medicine, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Prime Medicine, Inc. proxy season coverage: 2025-2026 (this page).
proxyvotesnow.com, “Prime Medicine (PRME) 2025-2026 Annual & Special Meetings”, https://proxyvotesnow.com/company/prime-medicine-inc/2026 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.